We are putting together a packed agenda that address the themes and topics our clinical trials community is talking about. Plus, plenty of networking opportunities to meet and mingle with other delegates and organizations working to innovate and improve the environment for clinical trials.


Download the full agenda here. 


November 8 & 9
7:30am – 8:45am

Join us in the morning to pick up your badge, enjoy some breakfast and explore the Innovation Showcase before the plenary sessions begin. 

Morning Sessions

November 8
8:50am – 12:00pm

KEYNOTE: Accelerating Clinical Trials Across Canada

  • Dr. PJ Devereaux, Director, Division of Perioperative Care, and Professor, Departments of Health Research Methods, Evidence, and Impact and Medicine, McMaster University; Associate Deputy Director and Senior Scientist, Population Health Research Institute

Clinical Trials at the Canadian Institutes of Health Research

  • Dr. Megan Bettle, Executive Director, Clinical Trials, Canadian Institutes of Health Research

Transformational Change in the Clinical Trials Environment: Challenges and Opportunities

  • Dr. Bradly Wouters, Executive Vice President, Science and Research, University Health Network

Bringing Strategy Home: Idea to Action

Life Sciences Strategy in Ontario 

Ontario’s World Class Environment for Clinical Trials 

Moderator: Nicole Dekort, President & CEO, Medtech Canada


  • Dr. Jason Field, President and CEO, Life Sciences Ontario
  • Brigitte Nolet, President & CEO of Roche Canada Pharma
  • Dr. Shurjeel Choudhri, Senior Vice President and Head of Medical and Scientific Affairs,  Bayer
  • Dr. PJ Devereaux, Director, Division of Perioperative Care, and Professor, Departments of Health Research Methods, Evidence, and Impact and Medicine, McMaster University; Associate Deputy Director and Senior Scientist, Population Health Research Institute

Afternoon Sessions

November 8
1:20pm – 5:05pm

Advancing Rare Disease Research in Canada’s Rare Disease Drug Strategy

  • Durhane Wong-Rieger, President,

Uniquely Rare – Navigating the Complexity of Rare Disease R&D.

  • Christina Archer, Vice President & Site Head Canada, Alexion

Building Capacity for Research in Community Hospitals in Canada – RICH-Canada Program

  • Dr. Jennifer Tsang, Physician Research Lead, Intensivist, Niagara Health; Physician Co-Lead, Critical Care Research Program, Niagara Health; Regional Deputy Research Director, Internal Medicine Residency Program, McMaster University; Associate Professor of Medicine, McMaster University

The MyTEMP Trial

  • Dr. Amit Garg, MD, FRCPC, FACP, MEd, PhD, Associate Dean for Clinical Research, at the Schulich School of Medicine & Dentistry, Professor of Medicine and Epidemiology & Biostatistics at Western University

Designing trials for vulnerable populations: An adaptive solution to studying cannabinoids and pediatric cancer

  • Dr. Lauren Kelly, Associate Professor, Depts. of Pharmacology and Therapeutics, and Community Health Sciences, University of Manitoba; Clinical Trials Director and Scientist, Children’s Hospital Research Institute of Manitoba; Clinical Trialist, George & Fay Yee Centre for Healthcare Innovation, Winnipeg, MB Scientific Director, the Canadian Collaborative for Childhood Cannabinoid Therapeutics (C4T); Director, Increasing capacity for Maternal and Paediatric Clinical Trials

Ethical considerations in adaptive platform trial design and analysis

  • Dr. Ross Upshur, Dalla Lana Chair in Clinical Public Health; Head of the Division of Clinical Public Health at the Dalla Lana School of Public Health; Senior Scientist at the Lunenfeld Tanenbaum Research Institute, Sinai Health

Research ethics and the Silent Genomes Project: Do current guidelines inadvertently reduce access to research for Indigenous patients?

  • Dr. Laura Arbour,  Professor in the Department of Medical Genetics at the University of British Columbia (UBC)

KEYNOTE: Diversity in Medicine

  • Dr. Chika Stacy Oriuwa, Physician, Changemaker, Transformative Leadership, Advocate for Diversity and Inclusion


November 8
5:05pm – 7:00pm

CTO 2023 Reception

Join us in celebrating the achievements of our clinical trials community over the past year.

Morning Sessions

November 9
8:55am – 12:10pm

KEYNOTE: A psychiatrist’s perspective on clinical trials: from therapeutic misconception to implementation science and points in between

  • Dr. David Goldbloom, former Senior Medical Advisor, Centre for Addiction and Mental Health, former Chair, Mental Health Commission of Canada, Professor of Psychiatry, University of Toronto, author

What’s Needed and What’s Next? Mental Health, Psychedelics, and Clinical Trials

  • Moderator: Clive Ward Able
  • Dr. Claudio Soares, MD, PhD, FRCPC, MBA; Professor and Head, Department of Psychiatry, Queen’s University School of Medicine
  • Dr. Amy Reichelt, Chief Innovation Officer at Purminds Neuropharma
  • David Clements, Executive Director of the Dimensions Health Research Collaborative, located at Queen’s University in the Faculty of Health Sciences

Harnessing Health Data for Better Care

  • Moderator: Dr. Ibukun Abejirinde, Applied Research Scientist, Women’s College Hospital Institute for Health System Solutions and Virtual Care; Assistant Professor, Dalla Lana School of Public Health; AMS Fellow in Compassion and Artificial Intelligence
  • Dr. Jane Philpott, Dean of the Faculty of Health Sciences, Director of the School of Medicine at Queen’s University; CEO of the Southeastern Ontario Academic Medical Organization
  • Dr. Jay Shaw, Canada Research Chair in Responsible Health Innovation (Tier 2); Assistant Professor, Department of Physical Therapy; Research Director, Artificial Intelligence, Ethics & Health, Joint Centre for Bioethics, University of Toronto; Scientist, Women’s College Hospital Institute for Health System Solutions and Virtual Care

Advancing Consent: Innovations from Acute Stroke Clinical Trials

  • Michel Shamy MD MA FRCPC, Attending Neurologist, The Ottawa Hospital; Scientist, Ottawa Hospital Research Institute; Associate Professor, Departments of Medicine & Epidemiology, University of Ottawa; Lead, Ethics & Humanities in Medicine, University of Ottawa

Afternoon Sessions

November 9
1:30pm – 3:30pm

Navigating Developments in the Clinical Research Landscape

  • Rebecca Barnes, Executive Director, N2 Canada
  • Erin Cherban, Chief Clinical Research Officer for the CIHR Canadian HIV Trials Network and the Centre for Advancing Health Outcomes

Public Health Emergency Research: SOLIDARITY Trial

  • Dr. Srinivas Murthy, Investigator, BC Children’s Hospital; Clinical Associate Professor, Department of Pediatrics, Faculty of Medicine, University of British Columbia

COVID-19:  Research Lessons from the Pandemic

  • Dr. John Marshall, Professor of Surgery at the University of Toronto; Intensivist at St. Michael’s Hospital

The Next Generation of Lived Perspectives in Clinical Trials

  • Trinity Lowthian, Youth Mentor in Patient Engagement; Student, Honours Bachelor of Food and Nutrition Sciences, University of Ottawa; Team Canada Para-Fencer
  • Emily Chan, Social Worker, Holland Bloorview Kids Rehabilitation Hospital; Advocate for Disability Rights
Attendance at our conference may be eligible for SOCRA continuing education credits. All conference delegates may request a certificate of attendance.